Abstract
Description: The purpose of this best practice advice article is to describe the indications for screening for cervical cancer in asymptomatic, average-risk women aged 21 years or older. Methods: The evidence reviewed in this work is a distillation of relevant publications (including systematic reviews) used to support current guidelines. Best Practice Advice 1: Clinicians should not screen averagerisk women younger than 21 years for cervical cancer. Best Practice Advice 2: Clinicians should start screening average-risk women for cervical cancer at age 21 years once every 3 years with cytology (cytologic tests without human papillomavirus [HPV] tests). Best Practice Advice 3: Clinicians should not screen averagerisk women for cervical cancer with cytology more often than once every 3 years. Best Practice Advice 4: Clinicians may use a combination of cytology and HPV testing once every 5 years in average-risk women aged 30 years or older who prefer screening less often than every 3 years. Best Practice Advice 5: Clinicians should not perform HPV testing in average-risk women younger than 30 years. Best Practice Advice 6: Clinicians should stop screening average-risk women older than 65 years for cervical cancer if they have had 3 consecutive negative cytology results or 2 consecutive negative cytology plus HPV test results within 10 years, with the most recent test performed within 5 years. Best Practice Advice 7: Clinicians should not screen averagerisk women of any age for cervical cancer if they have had a hysterectomy with removal of the cervix.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 851-859 |
| Number of pages | 9 |
| Journal | Annals of internal medicine |
| Volume | 162 |
| Issue number | 12 |
| DOIs | |
| State | Published - Jun 16 2015 |
Fingerprint
Cite this
Cervical Cancer screening in average-risk women : Best practice advice from the clinical guidelines committee of the American College of Physicians. / Sawaya, George F.; Kulasingam, Shalini; Denberg, Thomas D.; Qaseem, Amir.
In: Annals of internal medicine, Vol. 162, No. 12, 16.06.2015, p. 851-859.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Cervical Cancer screening in average-risk women
T2 - Best practice advice from the clinical guidelines committee of the American College of Physicians
AU - Sawaya, George F.
AU - Kulasingam, Shalini
AU - Denberg, Thomas D.
AU - Qaseem, Amir
PY - 2015/6/16
Y1 - 2015/6/16
N2 - Description: The purpose of this best practice advice article is to describe the indications for screening for cervical cancer in asymptomatic, average-risk women aged 21 years or older. Methods: The evidence reviewed in this work is a distillation of relevant publications (including systematic reviews) used to support current guidelines. Best Practice Advice 1: Clinicians should not screen averagerisk women younger than 21 years for cervical cancer. Best Practice Advice 2: Clinicians should start screening average-risk women for cervical cancer at age 21 years once every 3 years with cytology (cytologic tests without human papillomavirus [HPV] tests). Best Practice Advice 3: Clinicians should not screen averagerisk women for cervical cancer with cytology more often than once every 3 years. Best Practice Advice 4: Clinicians may use a combination of cytology and HPV testing once every 5 years in average-risk women aged 30 years or older who prefer screening less often than every 3 years. Best Practice Advice 5: Clinicians should not perform HPV testing in average-risk women younger than 30 years. Best Practice Advice 6: Clinicians should stop screening average-risk women older than 65 years for cervical cancer if they have had 3 consecutive negative cytology results or 2 consecutive negative cytology plus HPV test results within 10 years, with the most recent test performed within 5 years. Best Practice Advice 7: Clinicians should not screen averagerisk women of any age for cervical cancer if they have had a hysterectomy with removal of the cervix.
AB - Description: The purpose of this best practice advice article is to describe the indications for screening for cervical cancer in asymptomatic, average-risk women aged 21 years or older. Methods: The evidence reviewed in this work is a distillation of relevant publications (including systematic reviews) used to support current guidelines. Best Practice Advice 1: Clinicians should not screen averagerisk women younger than 21 years for cervical cancer. Best Practice Advice 2: Clinicians should start screening average-risk women for cervical cancer at age 21 years once every 3 years with cytology (cytologic tests without human papillomavirus [HPV] tests). Best Practice Advice 3: Clinicians should not screen averagerisk women for cervical cancer with cytology more often than once every 3 years. Best Practice Advice 4: Clinicians may use a combination of cytology and HPV testing once every 5 years in average-risk women aged 30 years or older who prefer screening less often than every 3 years. Best Practice Advice 5: Clinicians should not perform HPV testing in average-risk women younger than 30 years. Best Practice Advice 6: Clinicians should stop screening average-risk women older than 65 years for cervical cancer if they have had 3 consecutive negative cytology results or 2 consecutive negative cytology plus HPV test results within 10 years, with the most recent test performed within 5 years. Best Practice Advice 7: Clinicians should not screen averagerisk women of any age for cervical cancer if they have had a hysterectomy with removal of the cervix.
UR - http://www.scopus.com/inward/record.url?scp=84932190843&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84932190843&partnerID=8YFLogxK
U2 - 10.7326/M14-2426
DO - 10.7326/M14-2426
M3 - Article
C2 - 25928075
AN - SCOPUS:84932190843
VL - 162
SP - 851
EP - 859
JO - Annals of Internal Medicine
JF - Annals of Internal Medicine
SN - 0003-4819
IS - 12
ER -